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Ketoprofen is a potent nonsteroidal anti-inflammatory drug used for the treatment of in-
flammatory diseases and musculoskeletal injuries. Taking into account the increasing
consumption of this drug, it is important to develop a rapid, easy, and reliable analytical
strategy for its quality control. In this work, we present a novel method for ketoprofen
determination, based on its quenching effect produced in the fluorescence of CdTe
quantum dots modified by mercaptopropionic acid. Under optimized conditions, the
method was linear in the range of 7.5e100 mg/mL, with a detection limit of 2.3 mg/mL and
relative standard deviations lower than 2%. It was applied to the determination of keto-
profen in pharmaceutical formulations, obtaining results in good agreement with those
provided by the manufacturer.
Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license.1. Introduction Variousmethodshavebeendescribed inscientific literatures forKetoprofen (KTP), 2-(3-benzoylphenyl) propionic acid, is a
potent nonsteroidal anti-inflammatory drug used for the treat-
ment of inflammatory diseases and musculoskeletal injuries.
KTP also presents analgesic and antipyretic activity [1,2] and
relievespainassociatedwithbothrheumaticandnonrheumatic
inflammatory disorders, vascular headaches, and dysmenor-
rhea. Taking into account the increased use of KTP and new
formulations entering the market, it is important to have sim-
ple, accurate, and rapid methods for quality control analyses.cal and Analytical Chemi
rent-Martı´nez).
ministration, Taiwan. Publthe determination of KTP, including gas [3] and liquid [4,5]
chromatography, capillary electrophoresis [6], potentiometry
[7], spectrophotometry [8], terbium-sensitized luminescence [1],
and chemiluminescence [2,9]. However, due to the nonfluores-
cent nature of KTP, its fluorometric determination has not been
reported up to date, even after derivatization.
Colloidal nanocrystals, also known as quantum dots (QDs),
are nanometer-scale semiconductor crystals, defined as parti-
cles with physical dimensions smaller than the exciton Bohr
radius. These monodispersed nanoparticles are made of a corestry, Faculty of Experimental Sciences, University of Jae´n, Campus
ished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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CdSe, CdTe, CdS, and ZnSe), IIIBeVB (e.g., InP and InAs), or
IVBeVIB (e.g., PbSe) groups, surrounded by an organic capping
layer of passivating molecules, with a diameter typically
ranging from 1 nm to 10 nm [10,11]. QDs display superior
luminescent properties, including high quantum yield of fluo-
rescence, broad excitation spectrum, narrow/symmetric
emission spectrum, size- and composition-tunable emission
wavelength, high photobleaching threshold, and excellent
photostability. Therefore, thanks to recent advances in nano-
technology and nanomaterials, QDs are replacing traditional
organic fluorophores in various fluorescence systems. They can
be prepared readily in aqueousmedia ormadewater soluble by
appropriate cappingwith hydrophilic ligands [12]. Compared to
the traditional organic metallic method used in the aqueous
synthesis, QDs are stabilized by some functional ligands, such
as mercaptopropionic acid (MPA), thioglycolic acid, and gluta-
thione, and exhibit some unique properties such as lower cost,
less toxicity, water solubility, and biocompatibility [13].
In this work, MPA-capped CdTe QDs of different particle
sizes were synthesized in an aqueous medium and applied to
the quantitative determination of KTP. The described proce-
dure is based on the quenching provoked by the analyte over
the fluorescence of QDs. To the best of our knowledge, this is
the first strategy based on the use of QDs for the determina-
tion of this analyte and the first fluorometric method for KTP
quantification. The procedure described here is rapid and
simple, and was applied successfully to the analysis of phar-
maceutical formulations containing KTP.2. Methods
2.1. Reagents and solutions
For the synthesis of the CdTe QDs, tellurium powder (200
mesh, 99.8%), sodium borohydride (NaBH4, 99%), and cad-
mium chloride hemi (pentahydrate) (CdCl2$2.5H2O, 99%) were
purchased from Sigma-Aldrich (St Louis, MO, USA); MPA (99%)
and absolute ethanol (99.5%) were obtained from Fluka (St
Louis) and Panreac (Barcelona, Spain), respectively. QD solu-
tions were prepared by dissolving a certain amount of dried
nanocrystals in ultrapure water and used directly.
KTP (99.9%; Sigma-Aldrich, Madrid, Spain) stock solution of
550 mg/mL was prepared by dissolving the required weight in
80% methanol:water (v:v). The stock solution was kept in the
dark under refrigeration at 4C, where it remained stable for at
least 1month. Methanol (MeOH, 99.5%), hydrochloric acid (HCl,
37%), sodium hydroxide (NaOH, 98%), and sodium dihydrogen
phosphate 2-hydrate (NaH2PO4$2H2O, 99%) were obtained from
Panreac, all of which were of reagent grade. NaOH and HCl so-
lutions (both 1.0 M) were used to adjust the pHwhen required.
All reagents used in the interference study were obtained
from Sigma-Aldrich and were of reagent grade.
2.2. Instrumentation
For the characterization of the synthesized QDs, absorbance
and fluorescence spectra were recorded on a Jasco V-660
spectrophotometer and a PerkinElmer LS-50B luminescencespectrometer (PerkinElmer, Lisboa, Portugal), respectively.
Centrifugation of QDs was performed using a ThermoElectron
Jouan BR4I refrigerated centrifuge (Thermo Scientific Inc.;
Waltham, MA, USA).
Luminescence measurements for KTP determination were
performed on a Cary-Eclipse luminescence spectrometer
(Varian Inc., Mulgrave, Australia) controlled by a computer
equipped with a Cary-Eclipse (Varian Inc.) software package
for data collection and processing. The excitation and emis-
sion slit widths were set at 5 nm and 10 nm, respectively. The
detector voltage was 470 V, and the excitation and emission
wavelengths were 285 nm and 628 nm, respectively. A Hellma
(Mu¨llheim, Baden, Germany) 101-QS quartz cell, with a light
path of 10 mm and an inner volume of 3500 mL, was used for
fluorescencemeasurements. All experiments were carried out
at room temperature.
X-ray powder diffraction spectra were recorded using a
Philips X’Pert X-ray MPD diffractometer (Philips Analytical,
now Panalytical; Almelo, The Netherlands) (Cu Ka radiation).2.3. Synthesis of QDs
MPA-capped CdTe QDs were synthesized following the proce-
dure described by Zou et al [14], with some modifications.
Briefly, 1.6  103 mol NaHB4 reacted with 0.4  103 mol tellu-
rium powder in N2-saturated water in a 50 mL flask at 80C for
30 minutes under constant stirring. The resulting NaHTe solu-
tion was transferred to another flask containing 4.0  103 mol
CdCl2 and6.8 103molMPA in100mLN2-saturatedwater. The
pH of the solution was adjusted to 11.5 by the addition of 1.0 M
NaOH.TheCd2þ:Te2:MPAmolar ratiowasfixedas1:0.1:1.7.The
CdTe QD size was tuned by varying the heating time. QDs were
further purified by precipitation with absolute ethanol to
remove contaminants. The precipitate fractions were subse-
quently centrifuged, vacuum dried, and kept in a refrigerator.
All the fractions obtainedwere resuspended in deionizedwater
maintaining the initial synthesis concentration.2.4. Characterization of QDs
In the synthesis process described above, four fractions of QDs
were obtained. The size of the synthesized nanoparticles
decreased from 3.6 nm to 2.3 nm.
Photochemical and electrical properties of QDs are strongly
influenced by the nanoparticle size. Therefore, their reactivity
and analytical signal could vary with the diameter, which was
calculated using the following expression [15]:
D ¼ 9:8127 107l3  1:7147 103 l2 þ ð1:0064Þ l 194:84
[1]
where D is the diameter of the nanocrystals (nm) and l is
thewavelength ofmaximumabsorbance corresponding to the
first excitonic absorption peak of the crystal.
Aiming at assessing size dispersion, the emission peak
width, considered as the full width at half maximum (FWHM),
was determined. It was verified that FWHMvalues varied from
51 nm for the bigger QDs (3.6 nm diameter) to 37 nm for the
smaller ones (2.3 nm diameter), which confirmed a good
monodispersity. Crystallinity of the synthesized nanocrystals
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average particle size of the CdTe QDs calculated from FWHM
using Scherrer equation was in agreement with the values
provided by Yu et al’s [15] expression.
Molar concentrations of nanocrystals of different sizes can
be determined by recording the absorption spectrum of an
aqueous CdTe QD solution with a known mass concentration
and establishing first the extinction coefficient (ε) using the
following equation [15]: ε ¼ 3450 DE (D)2.4, where DE is the
transition energy (eV) corresponding to the first absorption
peak. Knowing ε and absorbance of CdTe QD solution, molar
concentration can be obtained by applying the LamberteBeer
law.
2.5. Sample preparation
Several pharmaceutical formulations available in the Spanish
Pharmacopoeia were analyzed, in the forms of tablets and
ampoules. For tablets, three of each pharmaceutical formu-
lationwereweighed accurately and ground finely. A portion of
the powder obtained was transferred to a 50 mL volumetric
flask and dissolved in 80% MeOH:H2O (v:v) solution. After
sonication, the solution was filtered, if required, using a cel-
lulose acetate filter (0.45 mm pore size; Millipore, Bedford, MA,
USA) and stored at 4C until analysis. For the ampoules, no
pretreatment was required. In all cases, appropriate dilutions
with 300 mM NaH2PO4/NaOH (pH 7.5) were made when
necessary.
2.6. Procedures
The following solutions were used for the preparation of
standard and sample solutions: (1) 10 mM QDs (3.6 nm diam-
eter) solution; (2) 600 mM NaH2PO4/NaOH buffer (pH 7.5); and
(3) 550 mg/mL KTP stock solution.
For the preparation of standard/sample solutions, 1.5 mL
and 5 mL of QD and buffer solutions, respectively, were added
to 10 mL volumetric flasks. Appropriate volumes of KTP stock
or sample solutions were then added to yield KTP concen-
trations in the range of 7.5e100 mg/mL, and the flasks were
made up to volumewith deionizedwater. Then, the analyticalFig. 1 e X-ray diffraction pattern of the CdTe quantum dots.signal was measured in a 1-cm quartz cuvette at 285/628 nm/
nm (lexc/lem). Taking into account that the measured signal
was quenched fluorescence, the blank solution was always
measured in the first place and the voltage of the detector was
adjusted to obtain the highest possible analytical signal,
usually observed at 470 V.3. Results and discussion
3.1. Chemical variables
Preliminary studies showed that KTP interacted with MPA-
capped CdTe QDs reducing their photoluminescence emis-
sion by means of a quenching mechanism. The luminescence
response of QDs was related directly to the amount of KTP in
the sample solution. A possible mechanism of this quenching
effect relies on the interactions between electronedonor
groups on the KTP molecule and incompletely coordinated
Cd2þ on the QDs surface, resulting in the establishment of
mid-gap energy levels that act as electron-trapping states
preventing electronehole recombination and quenching
nanocrystal photoluminescence.
In this section, the size and concentration of QDs, pH of
solutions, and ionic strengthwere examined in order to obtain
the best analytical signal.
Four sizes of QDs (2.3 nm, 2.9 nm, 3.2 nm, and 3.6 nm), each
one at different pH values, were evaluated. For pH values < 7,
precipitate formed in all cases. This effect is in agreement
with other studies [16], in which an acidic pH is avoided if QDs
capped with carboxylic acids (such as MPA) are used. The
reason is that the negative charge of the surface of QDs de-
creases at an acidic pH, and the particles tend to aggregate and
precipitate. As a result, the effect of pH was studied in the pH
range of 7e12.5. The highest net signal was obtained at pH 7.5
in all cases. Then, the effect of the ionic strength on the
analytical signal was studied using NaH2PO4/NaOH buffer at
pH 7.5, in the range of 0e400 mM (Fig. 2). The analytical signal
was observed to increase up to 300 mM and then remained
constant. Hence, a 300 mMNaH2PO4/NaOH buffer was used to
prepare all solutions.R
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Fig. 2 e Study of the influence of NaH2PO4/NaOH buffer
solution in the analytical signal, using a solution
containing 50 mg/mL KTP and 1.5 mM QDs of 3.6 nm
diameter. KTP [ ketoprofen; RSD [ relative standard
deviation.
Fig. 4 e Influence of QD concentrations for the 3.6 nm
diameter, using a solution containing 80 mg/mL KTP.
KTP [ ketoprofen; RSD [ relative standard deviation.
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and concentration of QDs were investigated. Here three
different ranges of concentrations were established according
to the QDs sizes: 0.5e2 mM (diameter 3.6 nm), 1e4 mM (di-
ameters 2.9 nm and 3.2 nm) and 3e7 mM (diameter 2.3 nm).
The best quenching signal was obtained at 3.6 nm diameter
(Fig. 3) and 1e1.5 mM QDs (Fig. 4). Finally, a 1.5 mM solution of
QDs (3.6 nm diameter) in 300 mM NaH2PO4/NaOH buffer (pH
7.5) was selected.
Stability of the QDseKTP solutions was examined under
optimum conditions. The analytical signal was observed to
increase up to 5 minutes after the mixing of solutions, remain
stable for at least 40 minutes, and start to decrease thereafter.
Therefore, the analytical signal was measured at 5e10 mi-
nutes after the mixing of QDs and KTP solutions.
3.2. Instrumental variables
The most outstanding characteristics of QDs are their broad
absorption spectra, enabling excitation at a wider range of
wavelengths, and symmetric and narrow emission spectra. In
addition, the same particles of different sizes present specific
emission wavelengths, and this emission increases propor-
tionally with QDs diameters through a red-shift phenomenon
[10]. The QD fluorescence spectra for the four different sized
QDs assayed in this work (2.3 nm, 2.9 nm, 3.2 nm, and 3.6 nm)
showed maximum emission wavelengths at 545 nm, 570 nm,
588 nm, and 628 nm, respectively.
Taking into account that the optimum size of QDs for the
determination of KTP was 3.6 nm, the selected wavelengths
were 285/628 nm/nm. Then, the emission and excitation
slits (5e20 nm), and voltage of the photomultiplier tube
(400e800 V) were optimized to obtain the best sensitivity.
Results showed that, under the optimumconditions described
previously, the best signal was obtained when instrumental
conditions were fixed to provide the highest possible signal
from the blank solution (QDs in 300 mM NaH2PO4/NaOH
buffer). Finally, the selected excitation and emission slits wereFig. 3 e Study of the influence of QD diameter, using a
solution containing 90 mg/mL KTP. The following QD
concentrations were used in this study: 1.5 mM (diameter
3.6 nm), 2 mM (diameters 2.9 nm and 3.2 nm), and 5 mM
(diameter 2.3 nm). KTP [ ketoprofen; RSD [ relative
standard deviation.5 nm and 10 nm, respectively, whereas the voltage of the
photomultiplier tube was set at 470 V.
3.3. Figures of merit
The proposed method offered good linearity in the range of
7.5e100 mg/mL, the obtained data being fitted by standard
least-squares calibration. A detection limit of 2.3 mg/mL was
obtained. Detection and quantitation limits were estimated as
the concentrations of analyte that produced analytical signals
equal to three times and 10 times, respectively, the standard
deviation of the luminescence of the blank solution. Intra/
interday repeatability was established for 10 analyses of 25 mg/
mL KTP. Figures of merit are shown in Table 1.
Ruggedness and robustness of the method were also
examined using KTP in Orudis (capsules). The ruggedness of
the method was assessed by comparison of the intra- and
interday assay results undertaken by two analysts. The rela-
tive standard deviation (RSD) values (%) for intra- and interday
assays did not exceed 2% and 5%, respectively. The robustness
of the method was investigated under a variety of conditions
such as small changes in the pH of sample solution (7.3e7.7),
buffer concentration (0.28e0.32 M), and excitation/emission
wavelengths (2 nm). The percent recoveries for KTP were in
the range of 95e105% in all cases (considering the valueTable 1 e Analytical parameters.
Parameter
Calibration graph
Intercept 4.5643
Slope (mL/mg) 7.2138
Correlation coefficient 0.9992
Linear dynamic range (mg/mL) 7.5e100
Detection limit (mg/mL) 2.3
Quantitation limit (mg/mL) 7.5
Intraday RSD (%) (n ¼ 10)a 1.3
Interday RSD (%) (n ¼ 10)a 4.5
KTP ¼ ketoprofen; RSD ¼ relative standard deviation.
a 25 mg/mL KTP.
Table 2 e Applications and recovery study.
Pharmaceutical Added (mg) Recovery 
RSD (%)a
Ketoprofen Ratiopharm
(Ratiopharm Ltd, Madrid, Spain)b
25 100  2
50 98  1
100 101  2
Fastum (Guidotti Farma Ltd,
Barcelona, Spain)b
25 102  1
50 99  2
75 100  2
Orudis (Sanofi Aventis Ltd,
Barcelona, Spain)b
30 97  1
60 99  2
90 100  2
Orudis (Sanofi Aventis Ltd,
Barcelona, Spain)c
40 103  1
80 99  2
120 102  1
KTP ¼ ketoprofen; RSD ¼ relative standard deviation.
a n ¼ 3.
b 50 mg KTP/tablet.
c 50 mg KTP/mL.
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strating the robustness of the proposed method.
3.4. Interference study
The potential interfering effect of excipients commonly found
in pharmaceutical formulations containing KTP was also
studied. Experiments were carried out using a solution con-
taining 30 mg/mL of KTP. Tolerance level was defined as the
amount of foreign species that produced an error not
exceeding 2% in the determination of the analyte. The
tolerated interferent/analyte (w/w) ratio was higher than 100
for starch, glucose, saccharose, lactose, stearic acid, and
polyethylene glycol. As a result, KTP could be analyzed,
without significant errors, in the presence of high concentra-
tions of potentially interfering compounds in pharmaceutical
formulations.
3.5. Analytical applications
The proposed method was applied satisfactorily to the
determination of KTP in pharmaceutical formulations, in the
form of tablets (three pharmaceutical preparations) and am-
poules (one preparation). Samples were prepared as described
in the “Sample preparation” section. Three samples were
prepared from each pharmaceutical formulation, and the
average results are shown in Table 2. In all cases, the amounts
of KTP determined by the proposed method (50.0 mg/tablet,
51.0 mg/tablet, and 48.5 mg/tablet, and 51.5 mg/mL) were in
good agreement with those provided by the manufacturer
(50.0 mg/tablet, 50.0 mg/tablet, and 50.0 mg/tablet, and 50.0
mg/mL) for Ketoprofen Ratiopharm, Fastum, Orudis (tablets),
and Orudis (ampoules), respectively. A recovery study was
also performed in order to evaluate the accuracy of the
method. It was carried out by spiking three different levels of
KTP concentrations to the analyzed pharmaceuticals. The
obtained results are shown in Table 2, with recoveries ranging
from 97% up to 103% and RSDs lower than 4% in all cases.4. Conclusion
In this work, we proposed a simple and rapid analytical
methodology for the determination of KTP in pharmaceutical
formulations, needing no pretreatment but filtration or dilu-
tion of the samples. Taking into account that KTP does not
present native fluorescence, the use of CdTeeMPA QDs
allowed its quantification by taking advantage of the
quenching effect produced by the analyte over the fluores-
cence of QDs. Although this methodology is starting to be
employed in the pharmaceutical field, this is the first time that
the use of QDs was described for the quantification of KTP;
this method represents an alternative to other published
methods for pharmaceutical analysis. To demonstrate the
suitability of the method, pharmaceuticals in the form of
tablets and ampoules were analyzed. In addition, recovery
studies were performed, demonstrating the accuracy of the
proposed method.r e f e r e n c e s
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